LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis
NASDAQ:LFMDP - Nasdaq - US53216B2034
We assign a fundamental rating of 3 out of 10 to LFMDP. LFMDP was compared to 39 industry peers in the Health Care Technology industry. LFMDP may be in some trouble as it scores bad on both profitability and health. LFMDP is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
LFMDP had negative earnings in the past year.
In the past year LFMDP had a positive cash flow from operations.
LFMDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
1.2 Ratios
LFMDP has a Return On Assets of -35.30%. This is comparable to the rest of the industry: LFMDP outperforms 40.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.3% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMDP has a better Gross Margin (89.64%) than 91.89% of its industry peers.
LFMDP's Gross Margin has improved in the last couple of years.
LFMDP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 89.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
2. Health
2.1 Basic Checks
LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LFMDP has been increased compared to 1 year ago.
Compared to 5 years ago, LFMDP has more shares outstanding
LFMDP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.09 indicates that LFMDP is not in any danger for bankruptcy at the moment.
LFMDP has a Altman-Z score of 4.09. This is in the better half of the industry: LFMDP outperforms 75.68% of its industry peers.
LFMDP has a debt to FCF ratio of 1.72. This is a very positive value and a sign of high solvency as it would only need 1.72 years to pay back of all of its debts.
The Debt to FCF ratio of LFMDP (1.72) is better than 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.72 | ||
| Altman-Z | 4.09 |
ROIC/WACCN/A
WACC9.93%
2.3 Liquidity
LFMDP has a Current Ratio of 0.83. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMDP's Current ratio of 0.83 is on the low side compared to the rest of the industry. LFMDP is outperformed by 75.68% of its industry peers.
A Quick Ratio of 0.78 indicates that LFMDP may have some problems paying its short term obligations.
With a Quick ratio value of 0.78, LFMDP is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 34.69% over the past year.
Looking at the last year, LFMDP shows a very strong growth in Revenue. The Revenue has grown by 42.15%.
The Revenue has been growing by 79.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%
3.2 Future
LFMDP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.61% yearly.
Based on estimates for the next years, LFMDP will show a very strong growth in Revenue. The Revenue will grow by 28.23% on average per year.
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue Next Year38.86%
Revenue Next 2Y31.68%
Revenue Next 3Y26.42%
Revenue Next 5Y28.23%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMDP. In the last year negative earnings were reported.
Also next year LFMDP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFMDP is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 88.34 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 31.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.7%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.18%, LFMDP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 36.82, LFMDP pays a better dividend. On top of this LFMDP pays more dividend than 97.30% of the companies listed in the same industry.
LFMDP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.18% |
5.2 History
LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
The earnings of LFMDP are negative and hence is the payout ratio. LFMDP will probably not be able to sustain this dividend level.
DP-12.13%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
LIFEMD INC - LFMD 8 7/8 PERP
NASDAQ:LFMDP (1/17/2025, 8:12:14 PM)
21.8
-0.45 (-2.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners38.56%
Inst Owner ChangeN/A
Ins Owners17.06%
Ins Owner ChangeN/A
Market Cap938.93M
Analysts81.33
Price Target54.04 (147.89%)
Short Float %0%
Short Ratio0.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.18% |
Yearly Dividend0.09
Dividend Growth(5Y)N/A
DP-12.13%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.34%
Min EPS beat(2)-49.02%
Max EPS beat(2)-15.66%
EPS beat(4)1
Avg EPS beat(4)-17.42%
Min EPS beat(4)-49.02%
Max EPS beat(4)15.97%
EPS beat(8)2
Avg EPS beat(8)-40.52%
EPS beat(12)3
Avg EPS beat(12)-33.85%
EPS beat(16)5
Avg EPS beat(16)-81.42%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.71%
Max Revenue beat(2)2.94%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)8.61%
Revenue beat(8)5
Avg Revenue beat(8)-0.32%
Revenue beat(12)5
Avg Revenue beat(12)-2.02%
Revenue beat(16)5
Avg Revenue beat(16)-2.35%
PT rev (1m)21.55%
PT rev (3m)-1.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-183.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.86 | ||
| P/FCF | 88.34 | ||
| P/OCF | 43.36 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.25
FCFY1.13%
OCF(TTM)0.5
OCFY2.31%
SpS4.48
BVpS-0.18
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.3% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 89.64% | ||
| FCFM | 5.51% |
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
F-Score6
Asset Turnover2.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.72 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 124.1% | ||
| Cap/Sales | 5.71% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 4.09 |
F-Score6
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)251.46%
Cap/Depr(5y)170.88%
Cap/Sales(3y)5.58%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%
Revenue Next Year38.86%
Revenue Next 2Y31.68%
Revenue Next 3Y26.42%
Revenue Next 5Y28.23%
EBIT growth 1Y-37.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year187.06%
EBIT Next 3Y67.15%
EBIT Next 5Y59.57%
FCF growth 1Y129.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.8%
OCF growth 3YN/A
OCF growth 5YN/A